The invention relates to a process for the solid oral pharmaceuticalformulation of a pharmaceutically active ingredient such as levetiracetam,comprising a wet granulation of the pharmaceutically active ingredient andsimultaneous fluid bed drying such that, as the pharmaceutical blendgranulates it is simultaneously dried thus preventing it from becoming apaste. The invention therein thus provides a novel formulation preparationprocess characterized by a "combined" Granulation and Fluid Bed Drying processstep.
